Form 8-K - Current report:
SEC Accession No. 0001641172-25-010537
Filing Date
2025-05-15
Accepted
2025-05-15 08:30:33
Documents
15
Period of Report
2025-05-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 30763
2 EX-99.1 ex99-1.htm EX-99.1 67811
3 GRAPHIC ex99-1_001.jpg GRAPHIC 6681
  Complete submission text file 0001641172-25-010537.txt   291566

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE cocp-20250515.xsd EX-101.SCH 3035
5 XBRL LABEL FILE cocp-20250515_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE cocp-20250515_pre.xml EX-101.PRE 22372
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3538
Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

EIN.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38418 | Film No.: 25948925
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)